Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.

Fiche publication

Date publication

février 2022

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ARNOULD Laurent , Dr BERTAUT Aurélie , Dr COUDERT Bruno , Pr COUTANT Charles , Pr GHIRINGHELLI François , Dr LADOIRE Sylvain , Mme PARNALLAND Sophie , Mme TRUNTZER Caroline , Dr VINCENT Julie , Dr HERVIEU Alice , Dr FAVIER Laure , Dr BENGRINE-LEFEVRE Leila , Dr DESMOULINS Isabelle , Dr FUMET Jean-David , Dr HENNEQUIN Audrey , Dr ZANETTA Sylvie , Dr MAYEUR Didier , Dr GOUSSOT Vincent

Tous les auteurs :
Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35189537

Résumé

Patients with cancer are a population at high risk of severe infection from SARS-CoV-2. Patients with cancer regularly attend specialised healthcare centres for management and treatment, where they are in contact with healthcare workers (HCWs). Numerous recommendations target both patients with cancer and HCWs to minimise the spread of SARS-CoV-2 during these interactions.